Diagnostic tools in tuberculosis - Present and future

被引:21
作者
Salfinger, M [1 ]
Hale, YM
Driscoll, JR
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA
[2] Albany Med Coll, Dept Med, Albany, NY 12208 USA
[3] Florida Dept Hlth & Rehabil Serv, Bur Labs, Jacksonville, FL USA
关键词
laboratory service; nucleic acid amplification; microscopy; tuberculosis; public health; drug resistance; mycobacterium;
D O I
10.1159/000029252
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Leadership will play a major role in the management of tuberculosis in the future. Many populations, such as immunocompromised patients and immigrants from countries with a higher prevalence of tuberculosis, create a challenge for care and diagnosis. Mycobacterial laboratory testing has undergone many changes in the past 10 years with the advent of nucleic acid probes for identification of Mycobacterium tuberculosis, and more recently nucleic acid amplification and beyond where computer technology meets molecular biology. In the past, changes for tuberculosis testing were not incorporated rapidly, sometimes taking 20 years or more to be fully implemented. The dynamics of acceptance of change and more rapid implementation need to be understood. With the use of such programs as Fast Track for Tuberculosis Testing, this can be accomplished more readily. New technologies can be provided to all users of such a network within a short amount of time and health care providers can equally benefit from this novel approach. The tuberculosis laboratory cannot stand alone. It must work together with other players, in order to eliminate tuberculosis.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 25 条
[1]  
American Thoracic Society, 1983, AM REV RESPIR DIS, V128, P213
[2]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[3]  
Catanzaro A, 1997, AM J RESP CRIT CARE, V155, P1804, DOI 10.1164/ajrccm.155.5.9154896
[4]   LABORATORY CONTAMINATION OF MYCOBACTERIUM-TUBERCULOSIS CULTURES [J].
DUNLAP, NE ;
HARRIS, RH ;
BENJAMIN, WH ;
HARDEN, JW ;
HAFNER, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1702-1704
[5]   SEPARATION OF MYCOBACTERIUM-BOVIS BCG FROM MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-BOVIS BY USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF MYCOLIC ACIDS [J].
FLOYD, MM ;
SILCOX, VA ;
JONES, WD ;
BUTLER, WR ;
KILBURN, JO .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1327-1330
[6]   MULTIPLEXED BIOCHEMICAL ASSAYS WITH BIOLOGICAL CHIPS [J].
FODOR, SPA ;
RAVA, RP ;
HUANG, XHC ;
PEASE, AC ;
HOLMES, CP ;
ADAMS, CL .
NATURE, 1993, 364 (6437) :555-556
[7]   PSEUDOEPIDEMIC OF NONTUBERCULOUS MYCOBACTERIA DUE TO A CONTAMINATED BRONCHOSCOPE CLEANING MACHINE - REPORT OF AN OUTBREAK AND REVIEW OF THE LITERATURE [J].
GUBLER, JGH ;
SALFINGER, M ;
VONGRAEVENITZ, A .
CHEST, 1992, 101 (05) :1245-1249
[8]   Oligomer-chip technology [J].
Hoheisel, JD .
TRENDS IN BIOTECHNOLOGY, 1997, 15 (11) :465-469
[9]  
HOPEWELL PC, 1996, TUBERCULOSIS, P113
[10]  
Inderlied Clark B., 1995, P1385